Archivos de la Sociedad Española de Oftalmología | 2019
Response to anti-VEGF therapy in macular oedema secondary to acute retinal necrosis.
Abstract
Abstract A 55 year-old female patient with unilateral acute retinal necrosis (ARN) developed macular oedema (MO) after the resolution of her necrosis. The macular oedema (MO) was managed and controlled for four years with intravitreal anti-VEGF injections. Anti-VEGF therapy could be useful for the treatment of MO secondary to ARN, the same as for treating MO resulting from panuveitis, where its efficacy has been already demonstrated.